vs
Side-by-side financial comparison of BTCS Inc. (BTCS) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
BTCS Inc. is the larger business by last-quarter revenue ($7.1M vs $4.9M, roughly 1.4× Sensus Healthcare, Inc.). On growth, BTCS Inc. posted the faster year-over-year revenue change (205.5% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-9.8M). Over the past eight quarters, BTCS Inc.'s revenue compounded faster (296.4% CAGR vs -31.9%).
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
BTCS vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.1M | $4.9M |
| Net Profit | — | $-3.2M |
| Gross Margin | 12.4% | 38.4% |
| Operating Margin | — | -63.8% |
| Net Margin | — | -64.1% |
| Revenue YoY | 205.5% | -62.2% |
| Net Profit YoY | — | -304.9% |
| EPS (diluted) | $-1.58 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.1M | $4.9M | ||
| Q3 25 | $4.9M | $6.9M | ||
| Q2 25 | $2.8M | $7.3M | ||
| Q1 25 | $1.7M | $8.3M | ||
| Q4 24 | $2.3M | $13.1M | ||
| Q3 24 | $739.2K | $8.8M | ||
| Q2 24 | $561.2K | $9.2M | ||
| Q1 24 | $451.4K | $10.7M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $65.6M | $-943.0K | ||
| Q2 25 | $3.9M | $-1.0M | ||
| Q1 25 | $-17.3M | $-2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | $-9.0M | $1.2M | ||
| Q2 24 | $-6.7M | $1.6M | ||
| Q1 24 | $12.3M | $2.3M |
| Q4 25 | 12.4% | 38.4% | ||
| Q3 25 | 22.0% | 39.4% | ||
| Q2 25 | -2.9% | 39.7% | ||
| Q1 25 | 7.1% | 52.2% | ||
| Q4 24 | 2.9% | 54.4% | ||
| Q3 24 | 26.5% | 59.3% | ||
| Q2 24 | 69.9% | 58.7% | ||
| Q1 24 | 64.4% | 62.5% |
| Q4 25 | — | -63.8% | ||
| Q3 25 | — | -37.3% | ||
| Q2 25 | — | -26.6% | ||
| Q1 25 | — | -31.7% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 16.9% | ||
| Q2 24 | — | 21.5% | ||
| Q1 24 | — | 27.1% |
| Q4 25 | — | -64.1% | ||
| Q3 25 | 1328.1% | -13.7% | ||
| Q2 25 | 140.0% | -14.2% | ||
| Q1 25 | -1022.5% | -30.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -1223.0% | 13.7% | ||
| Q2 24 | -1198.9% | 17.4% | ||
| Q1 24 | 2715.3% | 21.3% |
| Q4 25 | $-1.58 | $-0.19 | ||
| Q3 25 | $1.30 | $-0.06 | ||
| Q2 25 | $0.14 | $-0.06 | ||
| Q1 25 | $-0.86 | $-0.16 | ||
| Q4 24 | $0.28 | $0.10 | ||
| Q3 24 | $-0.56 | $0.07 | ||
| Q2 24 | $-0.43 | $0.10 | ||
| Q1 24 | $0.63 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $139.4M | $48.1M |
| Total Assets | $214.6M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $22.1M | ||
| Q3 25 | $4.5M | $24.5M | ||
| Q2 25 | $639.2K | $22.2M | ||
| Q1 25 | $269.9K | $19.1M | ||
| Q4 24 | $2.0M | $22.1M | ||
| Q3 24 | $254.5K | $22.6M | ||
| Q2 24 | $536.7K | $19.0M | ||
| Q1 24 | $670.6K | $14.7M |
| Q4 25 | $139.4M | $48.1M | ||
| Q3 25 | $225.4M | $51.2M | ||
| Q2 25 | $31.1M | $52.1M | ||
| Q1 25 | $20.6M | $53.0M | ||
| Q4 24 | $34.0M | $55.8M | ||
| Q3 24 | $25.2M | $54.1M | ||
| Q2 24 | $33.1M | $52.9M | ||
| Q1 24 | $39.3M | $51.2M |
| Q4 25 | $214.6M | $53.0M | ||
| Q3 25 | $298.9M | $58.3M | ||
| Q2 25 | $40.8M | $58.9M | ||
| Q1 25 | $21.0M | $60.2M | ||
| Q4 24 | $38.2M | $62.2M | ||
| Q3 24 | $26.5M | $59.9M | ||
| Q2 24 | $33.8M | $58.2M | ||
| Q1 24 | $39.5M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.8M | $-2.2M |
| Free Cash FlowOCF − Capex | $-9.8M | $-2.4M |
| FCF MarginFCF / Revenue | -138.1% | -47.9% |
| Capex IntensityCapex / Revenue | 0.2% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-15.8M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.8M | $-2.2M | ||
| Q3 25 | $-2.8M | $2.3M | ||
| Q2 25 | $-1.3M | $3.1M | ||
| Q1 25 | $-1.9M | $-2.7M | ||
| Q4 24 | $-3.5M | $-827.0K | ||
| Q3 24 | $-695.2K | $4.0M | ||
| Q2 24 | $-924.1K | $4.2M | ||
| Q1 24 | $-769.0K | $-8.2M |
| Q4 25 | $-9.8M | $-2.4M | ||
| Q3 25 | $-2.8M | $2.3M | ||
| Q2 25 | $-1.3M | $3.1M | ||
| Q1 25 | $-1.9M | $-2.7M | ||
| Q4 24 | $-3.5M | $-1.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $-8.4M |
| Q4 25 | -138.1% | -47.9% | ||
| Q3 25 | -56.7% | 33.3% | ||
| Q2 25 | -48.2% | 42.2% | ||
| Q1 25 | -112.7% | -32.2% | ||
| Q4 24 | -152.2% | -8.6% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | -79.0% |
| Q4 25 | 0.2% | 3.2% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.1% | 0.4% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.34× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | -0.06× | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTCS
| Builder Plus | $5.9M | 83% |
| Other | $1.2M | 17% |
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
